On and effective as of August 23, 2022, the board of directors of TherapeuticsMD, Inc. appointed Mr. Justin Roberts as a director to fill a newly created vacancy on the Board as a result of the Board's increase in the size of the Board by one director to a total of nine directors. Mr. Roberts will serve until the Company's 2022 Annual Meeting of Stockholders or until his successor is duly elected or appointed or his earlier death or resignation. Mr. Roberts has not been appointed to any committees of the Board at this time.

As a director of the Company, Mr. Roberts is entitled to receive compensation in the same manner as the Company's other non-employee directors, described in the section entitled “Director Compensation” in the Company's Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2021, filed with the Securities and Exchange Commission on April 29, 2022, but he has elected not to receive any compensation for his service as a non-employeedirector at this time.